Our results showed that a three‐marker diagnostic model for ESCC had better diagnostic performance than a two‐marker model; however, further cohort studies and prospective studies are needed to explore the potential for clinical application of S100A7 as a diagnostic biomarker. The gene discussed is S100A7; the disease is esophageal squamous cell carcinoma.